COVID-19 Outcomes in Critically Ill Patients in New York City
In patients admitted to the hospital with COVID-19 in New York City, critical illness is common and associated with high frequency of invasive mechanical ventilation.
COVID19
Proposed Palliative Care Response Plans During the COVID-19 Pandemic
Clinicians have proposed a system-wide response plan for the delivery of high-quality palliative care across a continuum of conventional, contingency, and crisis capacity scenarios during the COVID-19 pandemic.
Merck Collaborating on Novel COVID-19 Vaccine, Oral Antiviral
The vaccine candidate is currently in preclinical development with clinical studies expected to begin later this year.
WHO Suspends Testing of Hydroxychloroquine in Patients With COVID-19
In light of recent findings, the hydroxychloroquine arm of the WHO global study has been paused temporarily.
Predictors of Care in Persons Under Investigation for COVID-19
The healthcare burden of the COVID-19 pandemic extends beyond patients who test positive for severe acute respiratory syndrome coronavirus 2.
Hydroxychloroquine or Chloroquine for COVID-19: Large Study Finds No Benefit
A multinational observational study evaluating the use of hydroxychloroquine or chloroquine, either as monotherapy or with a macrolide, found that these treatments may increase the risk of ventricular arrhythmia and death in patients hospitalized with COVID-19.
Adenovirus Type 5 Vectored COVID-19 Vaccine Tolerable, Immunogenic in Phase 1 Study
A total of 108 healthy adult volunteers 18 to 60 years old (mean age, 36.3 years old) with no history of COVID-19 infection were enrolled in the study.
Interim Data on Abbott ID NOW COVID-19 Rapid Test Performance Announced
An ongoing clinical study of the Abbott ID NOW™ COVID-19 rapid test shows strong agreement to lab-based molecular polymerase chain reaction instruments.
High Dose IVIG to Be Investigated for Severe COVID-19 in Phase 3 Trial
The FDA has approved Octapharma’s Investigational New Drug Application allowing the Company to initiate a phase 3 trial of Octagam® in patients with COVID-19 with severe disease progression.
COVID-19 Superinfections and Antimicrobial Resistance
Epidemiologic, clinical, microbiologic and antimicrobial resistance data on nosocomial superinfections during the coronavirus disease 2019 pandemic is needed to inform stewardship.
Next post in Lung Infection
